Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties

Journal of Neuroscience

Volumn 24, Issue 20, 2004, Pages 4875-4883

  Dietrich, Joerg ^a   Blumberg, Benjamin M ^a   Roshal, Mikhail ^a   Baker, Jeffrey V ^a   Hurley, Sean D ^a   Mayer Pröschel, Margot ^a,b   Mock, David J ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cell cycle; Differentiation; Glial precursors; HHV 6; Human; Proliferation

Indexed keywords

BIOCHEMICAL MARKER; BROXURIDINE; MYELIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTRON MICROSCOPY; ENDEMIC DISEASE; FETUS; GENE EXPRESSION; GLIA CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; INFLAMMATION; MITOSIS INHIBITION; NONHUMAN; OLIGODENDROGLIA; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; VIRUS GENE; VIRUS INFECTION;

ANTIGENS, DIFFERENTIATION; BROMODEOXYURIDINE; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYTOPATHOGENIC EFFECT, VIRAL; G1 PHASE; HERPESVIRUS 6, HUMAN; HUMANS; L-LACTATE DEHYDROGENASE; NEUROGLIA; S PHASE; STEM CELLS;

EID: 2442707812     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5584-03.2004     Document Type: Article

References (73)

1. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzalez-Scarano F (1998) The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia. J Neurovirol 4:486-494.
2. Bitsch A, Kuhlman T, Da Costa C, Bunkowski S, Polak T, Bruck W (2000) Tumoure necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia 29:366-375.
3. Blakemore WF, Keirstead HS (1999) The origin of remyelinating cells in the central nervous system. J Neuroimmunol 98:69-76.
4. Blumberg BM, Mock DJ, Powers JM, Ito M, Assouline JG, Baker JV, Chen B, Goodman AD (2000) The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol 16:159-178.
5. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517.
6. Bruck W, Kuhlmann T, Stadelmann C (2003) Remyelination in multiple sclerosis. J Neurol Sci 206:181-185.
7. Brune W, Menard C, Heesemann J, Koszinowski UH (2001) A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291:303-305.
8. Burd EM, Carrigan DR (1993) Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res 29:79-90.
9. Cardinali G, Gentile M, Cirone M, Zompetta C, Frati L, Faggioni A, Torrisi MR (1998) Viral glycoproteins accumulate in newly formed annulate lamellae following infection of lymphoid cells by human herpesvirus 6. J Virol 72:9738-9746.
10. Carrigan DR, Knox KK (1995) Bone marrow suppression by human herpesvirus-6: comparison of the A and B variants of the virus. Blood 86:835-836.
11. Carrigan DR, Harrington D, Knox KK (1996) Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 47:145-148.
12. Castillo JP, Kowalik TF (2002) Human cytomegalovirus immediate early proteins and cell growth control. Gene 290:19-34.
13. Cermelli C, Pietrosemoli P, Meacci M, Pecorari M, Sabbatini AM, Colombari B, Portolani M (1997) SupT-1: a cell system suitable for an efficient propagation of both HHV-7 and HHV-6 variants A and B. New Microbiol 20:187-196.
14. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404-6412.
15. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
16. Demmler GJ (1991) Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 13:315-329.
17. Dietrich J, Noble M, Mayer-Proschel M (2002) Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 40:65-77.
18. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE (1999) Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73:8040-8052.
19. Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss JD, Cogen P, Gaillard WD, Sato S, Theodore WH, Jacobson S (2003) Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61:1405-1411.
20. Duchala CS, Asotra K, Macklin WB (1995) Expression of cell surface markers and myelin proteins in cultured oligodendrocytes from neonatal brain of rat and mouse: a comparative study. Dev Neurosci 17:70-80.
21. Dyer CA, Hickey WF, Geisert Jr EE (1991) Myelin/oligodendrocyte-specific protein: a novel surface membrane protein that associates with microtubules. J Neurosci Res 28:607-613.
22. Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231-237.
23. Engell T (1989) A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand 79:428-430.
24. Flemington EK (2001) Herpesvirus lytic replication and the cell cycle: arresting new developments. J Virol 75:4475-4481.
25. Franklin RJ (2002) Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
26. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM (2003) Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 187:1365-1376.
27. Haase AT, Stowring L, Ventura P, Burks J, Ebers G, Tourtellotte W, Warren K (1984) Detection by hybridization of viral infection of the human central nervous system. Ann NY Acad Sci 436:103-108.
28. He J, McCarthy M, Zhou Y, Chandran B, Wood C (1996) Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70:1296-1300.
29. Horvat RT, Parmely MJ, Chandran B (1993) Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J Infect Dis 167:1274-1280.
30. Inoue Y, Yasukawa M, Fujita S (1997) Induction of T-cell apoptosis by human herpesvirus 6. J Virol 71:3751-3759.
31. Isegawa Y, Mukai T, Nakano K, Kagawa M, Chen J, Mori Y, Sunagawa T, Kawanishi K, Sashihara J, Hata A, Zou P, Kosuge H, Yamanishi K (1999) Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73:8053-8063.
32. Isomura H, Yoshida M, Namba H, Yamada M (2003) Interaction of human herpesvirus 6 with human CD34 positive cells. J Med Virol 70:444-450.
33. Ito M, Baker JV, Mock DJ, Goodman AD, Blumberg BM, Shrier DA, Powers JM (2000) Human herpesvirus 6-meningoencephalitis in an HIV patient with progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 100:337-341.
34. Johnson RT (2003) Emerging viral infections of the nervous system. J Neurovirol 9:140-147.
35. Kennedy P (2003) Reviews in neurovirology: an introduction. J Neurovirol 9:139-283.
36. Kosugi I, Shinmura Y, Kawasaki H, Arai Y, Li RY, Baba S, Tsutsui Y (2000) Cytomegalovirus infection of the central nervous system stem cells from mouse embryo: a model for developmental brain disorders induced by cytomegalovirus. Lab Invest 80:1373-1383.
37. Lee JC, Mayer-Proschel M, Rao MS (2000) Gliogenesis in the central nervous system. Glia 30:105-121.
38. Luppi M, Barozzi P, Morris C, Maiorana A, Garber R, Bonacorsi G, Donelli A, Marasca R, Tabilio A, Torelli G (1999) Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol 73:754-759.
39. Mamidi A, DeSimone JA, Pomerantz RJ (2002) Central nervous system infections in individuals with HIV-1 infection. J Neurovirol 8:158-167.
40. Mayne M, Cheadle C, Soldan SS, Cermelli C, Yamano Y, Akhyani N, Nagel JE, Taub DD, Becker KG, Jacobson S (2001) Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 75:11641-11650.
41. McCarthy M (2003) Newer viral encephalitides. Neurology 9:189-199.
42. McCutchan JA (1995) Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 21 [Suppl 2]:S196-S201.
43. McLarnon JG, Michikawa M, Kim SU (1993) Effects of tumor necrosis factor on inward potassium current and cell morphology in cultured human oligodendrocytes. Glia 9:120-126.
44. McLaurin J, D'Souza S, Stewart J, Blain M, Beaudet A, Nalbantoglu J, Antel JP (1995) Effect of tumor necrosis factor alpha and beta on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 13:369-381.
45. Mock DJ, Powers JM, Goodman AD, Blumenthal SR, Ergin N, Baker JV, Mattson DH, Assouline JG, Bergey EJ, Chen B, Epstein LG, Blumberg BM (1999) Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy. J Neurovirol 5:363-373.
46. Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME (1997) Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 52:301-308.
47. Oldstone MB (2002) Travels along the viral-immunobiology highway. Immunol Rev 185:54-68.
48. Oldstone MB, Holmstoen J, Welsh Jr RM (1977) Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J Cell Physiol 91:459-472.
49. Oldstone MB, Sinha YN, Blount P, Tishon A, Rodriguez M, von Wedel R, Lampert PW (1982) Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science 218:1125-1127.
50. Padilla JA, Nii S, Grose C (2003) Imaging of the varicella zoster virion in the viral highways: comparison with herpes simplex viruses 1 and 2, cytomegalovirus, pseudorabies virus, and human herpes viruses 6 and 7. J Med Virol 70 [Suppl 1]:S103-S110.
51. Patrone M, Percivalle E, Secchi M, Fiorina L, Pedrali-Noy G, Zoppe M, Baldanti F, Hahn G, Koszinowski UH, Milanesi G, Gallina A (2003) The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J Gen Virol 84:3359-3370.
52. Raine CS, Bonetti B, Cannella B (1998) Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev Neurol (Paris) 154:577-585.
53. Rao M, Noble M, Mayer-Proschel M (1998) A tripotential glial precursor cell is present in the developing spinal cord. Proc Natl Acad Sci USA 95:3996-4001.
54. Reed LJ, Muench H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
55. Rosenfeld CS, Rybka WB, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, Shadduck RK (1995) Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 23:626-629.
56. Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D (1998) U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci USA 95:13911-13916.
57. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
58. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW (1996) Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2:249-258.
59. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P (1999) CD46 is a cellular receptor for human herpesvirus 6. Cell 99:817-827.
60. Scolding NJ, Rayner PJ, Compston DA (1999) Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter. Neuroscience 89:1-4.
61. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P (1995) Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171:273-280.
62. Selmaj K, Raine CS (1988) Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Ann NY Acad Sci 540:568-570.
63. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S (2000) Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 47:306-313.
64. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA (1986) Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
65. Stemple DL, Anderson DJ (1992) Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 71:973-985.
66. Stewart JM, Houser OW, Baker Jr HL, O'Brien PC, Rodriguez M (1987) Magnetic resonance imaging and clinical relationships in multiple sclerosis. Mayo Clin Proc 62:174-184.
67. Tsoukas CD, Lambris JD (1993) Expression of EBV/C3d receptors on T cells: biological significance. Immunol Today 14:56-59.
68. Warrington AE, Barbarese E, Pfeiffer SE (1992) Stage specific, (04+GalC-) isolated oligodendrocyte progenitors produce MBP+ myelin in vitro. Dev Neurosci 14:93-97.
69. Whitley RJ, Gnann JW (2002) Viral encephalitis: familiar infections and emerging pathogens. Lancet 359:507-513.
70. Wiebusch L, Hagemeier C (1999) Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). J Virol 73:9274-9283.
71. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W (1994) Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 83:3052-3058.
72. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609.
73. Zhu Y, Gelbard HA, Roshal M, Pursell S, Jamieson BD, Planelles V (2001) Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J Virol 75:3791-3801.